Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 350 participants.

Also called NCT07521475

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 350 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07521475
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07521475. Randomized; no masking; primary purpose treatment. Start 2026-04-30 (actual); primary completion 2026-12-24 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
Acronym
EVOLVE
Condition
Type 2 Diabetes Mellitus
Intervention (Device)
Device: Omnipod M System with study CGM
Intervention (Device)
Standard Therapy plus study CGM
Lead sponsor
Insulet Corporation (class: industry)
Collaborator
Jaeb Center for Health Research (class: other)

Record details

Record id
cardio:ct-nct07521475
Content hash
4f8d3143297fd44c31fb46bb30956c2a4099b8a2968a27a0ecc57c42ad9a2fe1